KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.612 $13.48 Friday, 26th Apr 2024 ACOR stock ended at $0.661. During the day the stock fluctuated 0% from a day low at $0.661 to a day high of $0.661.
90 days $0.612 $17.15
52 weeks $0.449 $18.21

Historical Acorda Therapeutics prices

Date Open High Low Close Volume
Mar 07, 2016 $37.05 $37.05 $37.05 $37.05 552 800
Mar 04, 2016 $36.00 $36.00 $36.00 $36.00 453 700
Mar 03, 2016 $35.47 $35.47 $35.47 $35.47 581 900
Mar 02, 2016 $35.53 $35.53 $35.53 $35.53 791 000
Mar 01, 2016 $34.31 $34.31 $34.31 $34.31 516 000
Feb 29, 2016 $32.71 $32.71 $32.71 $32.71 589 800
Feb 26, 2016 $33.01 $33.01 $33.01 $33.01 622 800
Feb 25, 2016 $33.57 $33.57 $33.57 $33.57 471 700
Feb 24, 2016 $33.66 $33.66 $33.66 $33.66 602 600
Feb 23, 2016 $33.95 $33.95 $33.95 $33.95 597 800
Feb 22, 2016 $34.84 $34.84 $34.84 $34.84 514 100
Feb 19, 2016 $34.29 $34.29 $34.29 $34.29 605 100
Feb 18, 2016 $34.15 $34.15 $34.15 $34.15 664 200
Feb 17, 2016 $35.84 $35.84 $35.84 $35.84 946 300
Feb 16, 2016 $34.40 $34.40 $34.40 $34.40 603 000
Feb 12, 2016 $33.63 $33.63 $33.63 $33.63 918 800
Feb 11, 2016 $33.48 $33.48 $33.48 $33.48 1 101 700
Feb 10, 2016 $36.22 $36.22 $36.22 $36.22 1 084 700
Feb 09, 2016 $35.35 $35.35 $35.35 $35.35 813 600
Feb 08, 2016 $35.58 $35.58 $35.58 $35.58 569 600
Feb 05, 2016 $36.67 $36.67 $36.67 $36.67 473 600
Feb 04, 2016 $37.28 $37.28 $37.28 $37.28 509 100
Feb 03, 2016 $37.88 $37.88 $37.88 $37.88 564 100
Feb 02, 2016 $37.17 $37.17 $37.17 $37.17 404 100
Feb 01, 2016 $37.92 $37.92 $37.92 $37.92 524 500
Click to get the best stock tips daily for free!

About Acorda Therapeutics

Acorda Therapeutics Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT